MIF mRNA Expression and Soluble Levels in Acute Coronary Syndrome

Figure 4

MIF soluble levels in the different clinical manifestation of disease. STEMI patients present the highest soluble levels of MIF (11.21 ng/dL), followed by UA patients (10.34 ng/dL), and finally by NSTEMI patients (8.75 ng/dL). No significant difference was shown.